CN103766886A - Astragalus preparation - Google Patents
Astragalus preparation Download PDFInfo
- Publication number
- CN103766886A CN103766886A CN201210414374.9A CN201210414374A CN103766886A CN 103766886 A CN103766886 A CN 103766886A CN 201210414374 A CN201210414374 A CN 201210414374A CN 103766886 A CN103766886 A CN 103766886A
- Authority
- CN
- China
- Prior art keywords
- health food
- astragalus
- ferrous lactate
- fatigue
- auxiliary material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940005630 astragalus preparation Drugs 0.000 title 1
- 235000013402 health food Nutrition 0.000 claims abstract description 13
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 10
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 10
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 10
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 10
- 241001061264 Astragalus Species 0.000 claims abstract description 6
- 235000006533 astragalus Nutrition 0.000 claims abstract description 6
- 210000004233 talus Anatomy 0.000 claims abstract description 6
- 229940107666 astragalus root Drugs 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 4
- 230000002929 anti-fatigue Effects 0.000 abstract description 3
- 235000019206 astragalus extract Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a health food containing astragalus extract and used for relieving physical fatigue. The health food comprises the following active ingredients by weight: 50-90 percent of astragalus extract, 10-50 percent of ferrous lactate and an auxiliary material in balancing amount. The health food scientifically combines astragalus with ferrous lactate, remarkably improves the anti-fatigue effect and has no obvious side effect.
Description
Technical field
The present invention relates to health food technology field, what be specifically related to is a kind of health food for alleviating physical fatigue.
Background technology
Modern medicine thinks that fatigue is that body transfinites and the function that causes reduces and occur that the state of body discomfort, main manifestations are tired sleepy, can occur degradation simultaneous phenomenon under dizziness, forgetful, sleep quality.The factor relations such as tired generation and energy substance consumption, metabolite accumulation, homeostasis sexual maladjustment, free radical impact are close.Along with the reinforcement of people's health care consciousness, various anti-fatigue products arise at the historic moment, wherein Chinese medicine series products natural with it, safely, the advantage such as have no side effect, day by day receive people's concern, as aweto capsule, American Ginseng sheet etc.Therefore, exploitation has the health food of the alleviating physical fatigue of tcm characteristic, not only can make up the deficiency of modern medicine in treatment, the advantage of performance traditional Chinese medicine, and also its suitable crowd's scope is wide, and the market demand is large, has wide market prospects.
Summary of the invention
Object of the present invention is just to provide a kind of health food for alleviating physical fatigue.Not only dialectical prescription, the fundamentally root of relieving fatigue, also combines nutrient, hardening agent homenergic material, to promote antisecosis.
In order to realize the object of the invention, the active component and the weight content thereof that form this health food are: Astragalus Root P.E 50-90%, ferrous lactate 10-50%, remaining is auxiliary material.
The present invention preferably material combination is: Astragalus Root P.E 60-80%, ferrous lactate 20-40%, remaining is auxiliary material.
In the present invention, Astragalus Root P.E is no less than 20% containing astragalus polyose.
Compared with prior art, advantage of the present invention is: dialectical prescription in conjunction with nutrient, curative effect is clear and definite.
The Radix Astragali: be the root of legume astragalus mongolicus Astragalus memeranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Astragalus membranacus A.membranaceus (Fisch.) Bge..Main product in the Inner Mongol, the ground such as Shanxi, Heilungkiang.Two seasons of spring and autumn excavate, and remove fibrous root and root head, dry, section, raw with or honey process use.The Radix Astragali can promote the renewal of organism metabolism, antifatigue, promotion serum and hepatic protein; There is obvious diuresis, can eliminate Jishengshenqiwan urine albumen; Can improve anaemia animal phenomenon; The hypoglycemia that can raise, reduces hyperglycaemia; Can excitedly breathe; Can strengthen and regulate body's immunity, interferon system is had to facilitation, can improve the premunition of body; The multiple viral institute such as infected by influenza cytopathogenic effect has slight inhibitory action, and influenza virus infected has protective effect; There is antibacterial action more widely; The Radix Astragali, in cell is cultivated, can make cell number showed increased, and Growth of Cells is vigorous, life; Can strengthen myocardial contractive power, protection cardiovascular system, anti-arrhythmia cordis, coronary artery dilator and peripheral vascular, reduce blood pressure, and can reduce platelet adhesion reaction power, reduces thrombosis; Also have reducing blood lipid, anti-ageing, anti-anoxic, radioresistance, the effect such as protect the liver.
Ferrous lactate: this product is ferro element replenishers.Iron is the chief component composition of hemoglobin and myoglobins.Hemoglobin is the person that mainly takes oxygen in red blood cell, and myoglobins is the position that muscle cell is stored oxygen, and the needs of oxygen are provided during for muscular movement.With tricarboxylic circulate relevant most of enzymes and the equal iron content of the factor, or only in the time that existing, iron just plays a role.Body lacks iron, can cause and be short of physical strength etc.
The specific embodiment
The preparation of embodiment 1 capsule of the present invention
Astragalus Root P.E 90%, ferrous lactate 10%, remaining is auxiliary material.
The preparation of embodiment 2 tablets of the present invention
Astragalus Root P.E 50%, ferrous lactate 50%.Raw material is added to right amount of auxiliary materials, compressing tablet.
The preparation of embodiment 3 capsules of the present invention
Astragalus Root P.E 70%, ferrous lactate 30%, remaining is auxiliary material.
Claims (3)
1. for a health food for alleviating physical fatigue, the active component and the weight content thereof that form this health food are: Astragalus Root P.E 50-90%, ferrous lactate 10-50%, remaining is auxiliary material.
2. a kind of health food for alleviating physical fatigue as claimed in claim 1, is characterized in that, the active component and the weight content thereof that form this health food are: Astragalus Root P.E 60-80%, ferrous lactate 20-40%, remaining is auxiliary material.
3. a kind of health food for alleviating physical fatigue as described in claim 1-2, is characterized in that, Astragalus Root P.E is no less than 20% containing astragalus polyose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210414374.9A CN103766886A (en) | 2012-10-26 | 2012-10-26 | Astragalus preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210414374.9A CN103766886A (en) | 2012-10-26 | 2012-10-26 | Astragalus preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103766886A true CN103766886A (en) | 2014-05-07 |
Family
ID=50560011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210414374.9A Pending CN103766886A (en) | 2012-10-26 | 2012-10-26 | Astragalus preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103766886A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010035764A (en) * | 1999-10-02 | 2001-05-07 | 나호준 | The process and manufactures of health assist foods |
| CN1772036A (en) * | 2005-11-03 | 2006-05-17 | 上海中医药大学 | Application of astragalus extract in preparing antifatigue medicine |
| CN101322778A (en) * | 2008-07-22 | 2008-12-17 | 北京康比特体育科技股份有限公司 | Double-layer sustained release tablets for compensating iron and preparation thereof |
| CN101703623A (en) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | Capsule with effect of relieving physical fatigue |
| CN102370170A (en) * | 2011-08-18 | 2012-03-14 | 高益槐 | Health-care food for relieving physical fatigue and preparation method thereof |
-
2012
- 2012-10-26 CN CN201210414374.9A patent/CN103766886A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010035764A (en) * | 1999-10-02 | 2001-05-07 | 나호준 | The process and manufactures of health assist foods |
| CN1772036A (en) * | 2005-11-03 | 2006-05-17 | 上海中医药大学 | Application of astragalus extract in preparing antifatigue medicine |
| CN101322778A (en) * | 2008-07-22 | 2008-12-17 | 北京康比特体育科技股份有限公司 | Double-layer sustained release tablets for compensating iron and preparation thereof |
| CN101703623A (en) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | Capsule with effect of relieving physical fatigue |
| CN102370170A (en) * | 2011-08-18 | 2012-03-14 | 高益槐 | Health-care food for relieving physical fatigue and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105105139A (en) | Plum enzyme formula | |
| CN102948748A (en) | Anti-fatigue health care product | |
| CN103766885A (en) | Health food for alleviating physical fatigue | |
| CN102048153A (en) | Health-care food with effect of reducing fat and preparation method thereof | |
| CN103564087A (en) | Cordyceps militaris tea | |
| CN103800407A (en) | Health-care product composition | |
| CN103766888A (en) | Preparation containing American ginseng extract | |
| CN103766886A (en) | Astragalus preparation | |
| CN101406644A (en) | Medicament with function for reducing blood sugar | |
| CN103766881A (en) | Traditional Chinese medicine health product | |
| CN102885313A (en) | Anti-fatigue health care product | |
| CN103766882A (en) | Compound astragalus mongholicus preparation | |
| CN103766887A (en) | Preparation comprising astragalus mongholicus extract | |
| CN103798755A (en) | Anti-fatigue capsule | |
| CN103798756A (en) | Traditional Chinese medicine health food | |
| CN105534786A (en) | Special care toothpaste for middle aged and elderly people | |
| CN101991037B (en) | Angelica-aronia melanocarpa pill and manufacturing method thereof | |
| CN103798771A (en) | Traditional Chinese medicine extract-containing compound preparation | |
| CN103798772A (en) | Health-care product composition | |
| CN103571700A (en) | Cordyceps militaris health wine | |
| CN108079275A (en) | A kind of health Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN103798776A (en) | Health-care food | |
| CN103766884A (en) | Novel composite preparation agent | |
| CN103800548A (en) | Compound traditional chinese medicine | |
| CN103768246A (en) | Traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |